Showing results (291-300 of 325) with videos related to
Sort By:
Pageof 33
Clinical and Experimental Rheumatology|March 14, 2012
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitisLuca Quartuccio, Miriam Isola, Laura Corazza, et al.Pharmacological Research|May 15, 2020
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation statusSpinello Antinori, Maria Vittoria Cossu, Anna Lisa Ridolfo, et al.Clinical and Experimental Rheumatology|May 4, 2017
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC)Massimo Galli, Letizia Oreni, Francesco Saccardo, et al.Frontiers in Immunology|May 3, 2021
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study GroupFrancesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2019
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical DiseasesDelia Goletti, Assunta Navarra, Elisa Petruccioli, et al.European Journal of Internal Medicine|May 26, 2020
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, ItalyValentina Morena, Laura Milazzo, Letizia Oreni, et al.Journal of Autoimmunity|August 10, 2015
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre studyLuca Quartuccio, Francesca Zuliani, Laura Corazza, et al.JCI Insight|November 16, 2021
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune responseCristian Loretelli, Ahmed Abdelsalam, Francesca D'Addio, et al.Retrovirology|June 26, 2014
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyStefania Bellino, Antonella Tripiciano, Orietta Picconi, et al.Diabetes Care|September 30, 2020
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational StudySebastiano Bruno Solerte, Francesca D'Addio, Roberto Trevisan, et al.Pageof 33